How Gut Peptides, Ghrelin, and Leptin Tell Your Brain When to Eat or Stop Eating

Food intake is regulated by an orchestra of afferent signals including gut peptides (CCK, GLP-1, ghrelin), leptin, and neural vagus nerve signals that converge on the hypothalamus to control hunger and satiety.

Bray, G A·The Proceedings of the Nutrition Society·2000·Moderate EvidenceReview
RPEP-00583ReviewModerate Evidence2000RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Review
Evidence
Moderate Evidence
Sample
Not reported

What This Study Found

Food intake regulation involves convergent afferent signals from gut peptides (CCK, GLP-1, PYY, ghrelin), adipose tissue (leptin), vagal mechanoreceptors, and higher brain centers, all integrated by hypothalamic circuitry.

Key Numbers

How They Did This

Comprehensive review of afferent signaling in food intake regulation, covering pre-absorptive, absorptive, and post-absorptive signals from gut, adipose tissue, and neural pathways.

Why This Research Matters

Understanding the full network of appetite-regulating signals is essential for developing effective obesity and eating disorder treatments. Each signal represents a potential drug target.

The Bigger Picture

The obesity epidemic reflects a mismatch between our evolved appetite regulation system and modern food environments. Understanding each signal in this network is essential for developing targeted interventions.

What This Study Doesn't Tell Us

Review from 2000; some signaling pathways were still being characterized. The complexity of interactions between signals makes therapeutic targeting challenging.

Questions This Raises

  • ?Can combination therapies targeting multiple appetite signals be more effective?
  • ?Does obesity involve dysfunction in specific signal pathways?
  • ?Can appetite signaling be reset in people who have lost weight?

Trust & Context

Key Stat:
Multiple converging signals Hunger and satiety result from integration of gut peptides, fat hormones, nerve signals, and sensory inputs — not a single hunger switch
Evidence Grade:
Moderate evidence from a comprehensive review synthesizing data from multiple research groups on appetite signaling pathways.
Study Age:
Published in 2000. Appetite regulation research has expanded enormously, leading to GLP-1-based drugs (semaglutide) now transforming obesity treatment.
Original Title:
Afferent signals regulating food intake.
Published In:
The Proceedings of the Nutrition Society, 59(3), 373-84 (2000)
Authors:
Bray, G A
Database ID:
RPEP-00583

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / ObservationalSnapshot without intervening
This study
Case Report / Animal Study

Summarizes existing research on a topic.

What do these levels mean? →

Frequently Asked Questions

Why is appetite so hard to control?

Because it's regulated by dozens of converging signals from your gut, fat tissue, nerves, and brain. Willpower alone can't override this complex biological system, which is why drugs targeting specific signals (like GLP-1) are so effective.

What is ghrelin's role?

Ghrelin is the hunger hormone — it rises before meals to drive food-seeking behavior. It was newly discovered when this review was written and has since become a major target for appetite and GH research.

Read More on RethinkPeptides

Cite This Study

RPEP-00583·https://rethinkpeptides.com/research/RPEP-00583

APA

Bray, G A. (2000). Afferent signals regulating food intake.. The Proceedings of the Nutrition Society, 59(3), 373-84.

MLA

Bray, G A. "Afferent signals regulating food intake.." The Proceedings of the Nutrition Society, 2000.

RethinkPeptides

RethinkPeptides Research Database. "Afferent signals regulating food intake." RPEP-00583. Retrieved from https://rethinkpeptides.com/research/bray-2000-afferent-signals-regulating-food

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.